ARQ Arq, Inc.
Miscellaneous Chemical Products · Nasdaq · SEC CIK 1515156 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY7.3%
TTM net income YoY-966.8%
TTM EPS YoY-972.7%
Revenue 3-yr CAGR10.2%
Net income 3-yr CAGR—
Margins
Gross margin32.1%
Operating margin-38.8%
Net margin-39.0%
FCF margin1.1%
EBITDA margin-28.7%
Returns
ROE-25.4%
ROA-19.3%
ROIC (approx.)-18.5%
Asset turnover0.50x
Leverage & solvency
Liabilities / assets26.4%
Debt / equity0.16x
Current ratio1.20x
Interest coverage-17.76x
Cash quality & payout
Operating cash flow / net income-0.10x
Accruals ratio-21.2%
Payout ratio—
Capex / revenue2.8%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $38.21M | $29.88M | $29.05M | $29.43M | $35.07M | $28.58M | $27.25M | $27.04M |
| Cost of revenue | $23.04M | $18.37M | $19.11M | $25.44M | $24.96M | $19.07M | $17.33M | $17.24M |
| Gross profit | $15.17M | $11.51M | $9.94M | $3.99M | $10.11M | $9.52M | $9.91M | $9.80M |
| R&D expense | $754,000 | $958,000 | $982,000 | $1.20M | $2.57M | $2.70M | $874,000 | $709,000 |
| SG&A expense | $7.15M | $6.79M | $7.37M | $5.96M | $4.62M | $5.92M | $6.05M | $5.96M |
| Operating income | $3.12M | -$68,000 | -$982,000 | -$51.23M | -$1.07M | -$1.79M | $662,000 | $413,000 |
| Interest expense | $771,000 | $748,000 | $705,000 | $544,000 | $587,000 | $594,000 | $724,000 | $831,000 |
| Pretax income | $2.50M | -$733,000 | -$842,000 | -$49.31M | -$889,000 | -$2.37M | $203,000 | -$1.53M |
| Income tax | $0 | $0 | $0 | $12,000 | $0 | $0 | $0 | -$194,000 |
| Net income | $2.50M | -$733,000 | -$1.14M | -$50.03M | -$889,000 | -$2.37M | -$33,000 | -$1.34M |
| EBITDA | $7.24M | $3.47M | $1.59M | -$48.61M | $2.92M | $930,000 | $2.84M | $2.92M |
| EPS (basic) | 0.06 | -0.02 | -0.02 | — | -0.02 | -0.06 | 0.00 | — |
| EPS (diluted) | 0.06 | -0.02 | -0.02 | — | -0.02 | -0.06 | 0.00 | — |
| Weighted avg. shares (diluted) | 42.95M | 42.10M | 41.73M | — | 41.61M | 41.51M | 42.53M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $7.75M | $906,000 | $4.67M | $6.57M | $15.49M | $15.42M | $14.80M | $22.23M |
| Receivables | $20.21M | $20.03M | $15.95M | $14.98M | $14.36M | $15.55M | $15.37M | $14.88M |
| Inventory | $17.26M | $19.41M | $19.91M | $15.89M | $15.74M | $20.78M | $21.75M | $19.31M |
| Current assets | $50.94M | $47.24M | $46.05M | $43.85M | $43.93M | $50.66M | $48.23M | $52.36M |
| PP&E, net | $136.30M | $139.04M | $141.06M | $143.15M | $180.72M | $180.62M | $181.20M | $178.56M |
| Intangibles | $577,000 | $572,000 | $585,000 | $570,000 | $7.29M | $7.38M | $7.46M | $7.57M |
| Total assets | $233.41M | $233.01M | $232.13M | $230.97M | $277.95M | $284.54M | $283.67M | $284.37M |
| Current liabilities | $42.49M | $45.99M | $45.08M | $42.30M | $39.82M | $46.17M | $42.97M | $44.65M |
| Short-term debt | $20.26M | $22.51M | $21.98M | $20.01M | $17.05M | $19.96M | $17.75M | $15.45M |
| Long-term debt | $7.96M | $8.20M | $8.19M | $8.45M | $8.80M | $8.74M | $9.09M | $9.37M |
| Total debt | $28.22M | $30.70M | $30.18M | $28.46M | $25.85M | $28.70M | $26.84M | $24.82M |
| Total liabilities | $61.51M | $64.79M | $64.32M | $62.62M | $60.79M | $67.77M | $65.50M | $67.09M |
| Shareholders' equity | $171.90M | $168.22M | $167.91M | $168.36M | $217.78M | $217.63M | $219.28M | $218.61M |
| Net debt | $20.46M | $29.80M | $25.50M | $21.89M | $10.36M | $13.28M | $12.04M | $2.59M |
| Shares outstanding | 44.17M | 42.89M | 42.88M | 42.73M | 42.69M | 42.58M | 42.16M | 42.02M |
| Cash flow statement | ||||||||
| Operating cash flow | $10.34M | -$2.72M | $64,000 | -$2.76M | $5.30M | $527,000 | -$5.80M | $5.21M |
| Capital expenditure | $780,000 | $1.23M | $740,000 | $783,000 | $2.20M | $1.88M | $3.71M | $42.96M |
| Free cash flow | $9.56M | -$3.96M | -$676,000 | -$3.54M | $3.10M | -$1.35M | -$9.51M | -$37.75M |
| Investing cash flow | -$934,000 | -$1.27M | -$754,000 | -$314,000 | -$2.32M | -$1.93M | -$3.60M | -$42.97M |
| Financing cash flow | -$2.50M | $278,000 | $1.51M | $2.62M | -$2.92M | $2.03M | $1.97M | $2.62M |
| Depreciation & amortization | $4.11M | $3.54M | $2.57M | $2.62M | $3.99M | $2.72M | $2.18M | $2.50M |
| Stock-based compensation | $1.18M | $1.04M | $891,000 | $840,000 | $1.05M | $734,000 | $736,000 | $530,000 |
Free plan shows the latest 8 periods; Pro shows all 58 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.